PMN
Income statement / Annual
Last year (2024), ProMIS Neurosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, ProMIS Neurosciences, Inc.'s net income was $2.78 B.
See ProMIS Neurosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$8,138.70 |
$1,401.39 |
$920.18 |
$348.74 |
$7,868.79 |
$2,002.08 |
$14,365.00 |
| Cost of Revenue |
$0.00
|
$10.44 M
|
$21.78 M
|
$5.85 M
|
$3.18 M
|
$4.74 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$10.44 M
|
-$21.78 M
|
-$5.84 M
|
-$3.18 M
|
-$4.73 M
|
$348.74
|
$7,868.79
|
$2,002.08
|
$14,365.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
-717.97
|
-2270.42
|
-5145.09
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$10.64 B
|
$7.88 M
|
$16.09 M
|
$4.95 M
|
$2.50 M
|
$3.63 M
|
$5.44 M
|
$3.15 M
|
$1.39 M
|
$763,961.00
|
| General & Administrative Expenses |
$6.19 B
|
$7.39 M
|
$7.29 M
|
$3.31 M
|
$1.95 M
|
$2.04 M
|
$2.02 M
|
$1.64 M
|
$1.17 M
|
$682,259.00
|
| Selling & Marketing Expenses |
$0.00
|
-$1.01 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.19 B
|
$6.38 M
|
$7.29 M
|
$3.31 M
|
$1.95 M
|
$2.04 M
|
$2.02 M
|
$1.64 M
|
$1.17 M
|
$682,259.00
|
| Other Expenses |
$0.00
|
-$5.81 M
|
$115,525.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$16.83 B
|
$8.45 M
|
$23.38 M
|
$8.26 M
|
$4.44 M
|
$5.66 M
|
$7.46 M
|
$4.79 M
|
$2.56 M
|
$1.45 M
|
| Cost And Expenses |
$0.00
|
$18.90 M
|
$23.38 M
|
$8.26 M
|
$4.44 M
|
$5.66 M
|
$7.46 M
|
$4.79 M
|
$2.56 M
|
$1.45 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$4,731.69
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$76.78 M
|
-$201,390.00
|
$282,064.00
|
$415,025.00
|
$0.00
|
$0.00
|
$0.00
|
$5,648.51
|
$15,888.00
|
$23,982.00
|
| Depreciation & Amortization |
-$19.53 B
|
$28,035.00
|
$15,185.00
|
$45,825.00
|
$12,334.00
|
$6,553.01
|
$4,898.57
|
$5,305.77
|
$4,963.92
|
$5,503.39
|
| EBITDA |
-$16.83 B |
-$17.81 M |
-$29.88 M |
-$9.33 M |
-$4.43 M |
-$5.66 M |
-$7.46 M |
-$4.78 M |
-$2.55 M |
-$1.51 M |
| EBITDA Ratio |
0
|
0
|
0
|
-1146.13
|
-3159.86
|
-6146.17
|
-21390.27
|
-606.99
|
-1275.52
|
-104.81
|
| Operating Income Ratio |
0
|
0
|
0
|
-1013.64
|
-3168.66
|
-6153.29
|
-21404.32
|
-607.67
|
-1278
|
-105.19
|
| Total Other Income/Expenses Net |
$19.61 B
|
$1.39 M
|
$7.20 M
|
-$1.50 M
|
$1.22 M
|
$0.00
|
$0.00
|
-$5,648.51
|
-$11,820.55
|
-$17,281.96
|
| Income Before Tax |
$2.78 B
|
-$17.51 M
|
-$18.06 M
|
-$9.24 M
|
-$4.44 M
|
-$5.66 M
|
-$7.46 M
|
-$4.79 M
|
-$2.57 M
|
-$1.53 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
-1135.63
|
-3168.66
|
-6153.29
|
-21404.32
|
-608.39
|
-1283.9
|
-106.4
|
| Income Tax Expense |
$0.00
|
-$167,895.00
|
-$5.32 M
|
$415,025.00
|
$0.14
|
-$0.00
|
-$156,242.43
|
$5,648.51
|
$11,820.00
|
$17,281.00
|
| Net Income |
$2.78 B
|
-$17.51 M
|
-$12.74 M
|
-$9.66 M
|
-$4.44 M
|
-$5.66 M
|
-$7.46 M
|
-$4.79 M
|
-$2.57 M
|
-$1.53 M
|
| Net Income Ratio |
0
|
0
|
0
|
-1186.62
|
-3168.66
|
-6153.29
|
-21404.32
|
-608.39
|
-1283.9
|
-106.4
|
| EPS |
0.1072 |
-1.42 |
-1.7 |
-1.67 |
-0.93 |
-1.31 |
-1.87 |
-1.4 |
-0.91 |
-0.85 |
| EPS Diluted |
0.105 |
-1.42 |
-1.7 |
-1.67 |
-0.93 |
-1.31 |
-1.87 |
-1.4 |
-0.91 |
-0.85 |
| Weighted Average Shares Out |
$25.92 M
|
$12.29 M
|
$7.50 M
|
$5.79 M
|
$4.76 M
|
$4.33 M
|
$3.99 M
|
$3.43 M
|
$2.83 M
|
$1.80 M
|
| Weighted Average Shares Out Diluted |
$26.46 M
|
$12.29 M
|
$7.50 M
|
$5.79 M
|
$4.76 M
|
$4.33 M
|
$3.99 M
|
$3.43 M
|
$2.83 M
|
$1.80 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
